Qritive featured as the application of the month on “Medical Imaging News“ about harnessing the power of AI to improve Cancer diagnosis.

Computer Vision News & Medical Imaging news

The Magazine of the Algorithm Community with Bruno Occhipinti, Chief Commercial Officer of Qritive, at MICCAI 2022.

Qritive is featured as the application of the month on “Medical Imaging News“ about harnessing the power of AI to improve Cancer diagnosis.

Read More

About Qritive

Qritive, headquartered in Singapore with operations in the US and India, is transforming digital pathology through advanced AI-powered solutions that support cancer diagnosis and improve health outcomes.

By leveraging cutting-edge deep learning technology, Qritive supports pathologists in the interpretation of pathology assessments and enhances pathology workflows—enabling faster, more accurate diagnoses and reducing time to treatment.

Qritive is committed to empowering healthcare professionals around the world with tools that promote collaboration and high performance, regardless of complexity or distance.

Get in Touch

Want to learn more about our solutions or explore potential collaborations?

Visit www.qritive.com or contact us at info@qritive.com